209 Arrhythmic storm in non ischemic patients treated with ICD device for primary prevention. Long-term follow-up and prognosis  by Manolis, Athanasios G. et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2011) 3, 55-71 67
Background and aim: The new pacemaker (PM) generations featuring
extended memory functions (MF) document the occurrence of arrhythmias
over periods of several months.  Recordings of all atrial episodes and their
characteristics contribute to the efficacious treatment of these patients.  How-
ever, ventricular arrhythmia (VA) characteristics and occurrences are less
well-known in this population.  The goal of this study was to evaluate the per-
tinence of MF at the ventricular level and to describe the MF-documented
VAs.
Methods & Results: the study involved  a  continuous series of 93 pts (M
66%, aged 75±10 yrs) implanted with SC or DC Kappa and EnPulse PMs
(Medtronic, MN, USA) for AVB 41%, SD 55%.  497 visits were analyzed
(follow-up at 7 months avg.) over a period from 2 to 81 months after implan-
tation, and occurrences of VA validated by EGMs, defined by at least 5 QRS
complexes >175/mn.  The number of episodes and the duration and heart rate
during the longest arrhythmia episodes were recorded.  24 pts (26%) average
ages 74 ± 13 yrs of whom 78% males, showed ventricular arrhythmias in 88
visits (18%).  The average number of episodes was 9 per follow-up (1-140),
average duration was 4 ±4 seconds (1-27 sec), and average rate was 214 ± 33
bpm. (174-307). The totality of the episodes were classified as non-sustained
ventricular tachycardia (NSVT).  The ejection fraction was 51±11%.  84%
showed cardiopathy : CAD (12), HCM(4) and DCM (4).  Statistical analysis
showed that age, pacing indication, pacing mode and cumulated percentage of
pacing are not relevant factors in NSVT.
Conclusion: VAs are observed in π of pts implanted for standard pacing
indications.  A major determining factor in the occurrence of NSVT is the
presence of an associated cardiopathy.  FMs featuring EGM recordings are a
tool for reliable diagnostic and monitoring of these events.  Further studies are
required to evaluate the prognostic significance of these VAs.  
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We suggested being interested in the theoretical and practical aspect of the
slew-rate measurement, to obtain an evaluation of the relation between this
measure and the other measures done during implantation and follow-up such
as the stimulation thresholds, the value of the EGM and the impedance. The
variation of this parameter will inform us about the quality of the interface
lead/myocardium.
Method: The study recruited 746 patients not selected a priori,
implanted for AV block (51%) or sinus dysfunction (47%). 847 leads were
retained to form 3 homogeneous and comparable groups for their physical,
electric characteristics and their site of implantation for atrial and ventricular
chambers. They correspond to the optimal characteristics (Gr1), acceptable
(Gr2) and not acceptable (Gr3) of sensing and pacing parameters usually
admitted by the literature.
Results: For auricular chamber, we retained a priori, 56 leads (Gr1), 168
for (Gr2) and 15 for (Gr3); the factorial discriminate analysis (FDA) was real-
ized from the variables of slew-rate, sensing per and post-op and threshold per
and post-op gives us a result of 83.7% of individuals good classified.
 For the ventricular chamber, we retained a priori, 183 leads (Gr1), 168 (Gr2)
and 9 (Gr3); the FDA realized from the same variables gives us a result of 80
% of individuals good classified. 
The comparison of the averages between groups for every variable shows a
significant difference between these groups as well as in the atrial and the ven-
tricular chambers. The data of the others leads (atrium n=94 and ventricle
n=154) were affected by the FDA calculation. 
Conclusion: The results shown a correlation between slew-rate and
electric parameters per and post-op for the 3 groups for atrial and ventricular
chambers; a new standard for sensing, pacing and slew-rate values were
defined as optimal, acceptable and no-acceptable.
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Accessory pathway (AP) ablation is the treatment of choice of symptomatic
patients (pts) with a Wolff-Parkinson-White (WPW) syndrome or pts with a
malignant form at electrophysiological study (EPS). WPW  can reappear after
ablation. The purpose of the study was to look for the risk factors of AP reap-
pearance and the clinical consequences.
Methods: AP ablation was performed in 327 pts aged from 8 to 77 years
(37±16), with a WPW. Ablation failed in 6 pts. In other pts, the anterograde
and retrograde conduction disappeared after AP radiofrequency ablation.
Reappearance of AP occurred in 48 pts from several hours to several years.
Their data were studied.
Results: There were no significant clinical differences between pts with
and without reappearance of AF, concerning the age (33±16 years vs 36±16),
the gender (male gender 28/48 vs 166/280), the reason of ablation (sponta-
neous malignant form: 10/48 vs 70/280; spontaneous AV reentrant tachycardia
(AVRT): 29/48 vs 176/280, asymptomatic with electrophysiological signs of
malignancy: 9/48 vs 38/280), the location of AP (left lateral AP: 21/48 vs 125/
280, posteroseptal  AP: 22/47 vs 119/280, anteroseptal: AP 5/47 vs 27/280).
During the follow up, among 9 of 45 pts asymptomatic before ablation but
with only inducible rapid AF at EPS, 2 pts became symptomatic and had
inducible AVRT at the control. 29 of 202 pts with spontaneous AVRT pre-
sented recurrences of AVRT, except one and a 2nd procedure was required.
Among 10 of 79 with syncope and signs of malignancy or spontaneous rapid
AF, 2 pts have lost the signs of malignancy at 2nd EPS; 2 pts who presented
only with rapid AF, had an AP with long refractory period but developed
incessant AVRT’s; 6 pts had still signs of malignancy, requiring a second pro-
cedure.
Conclusions: There was no significant clinical or electrophysiological
cause that explains the reappearance of AP after ablation. The reappearance of
conduction is generally associated with reappearance of all properties of AP
associated with malignancy or AVRT, except in some cases. Pts without
AVRT before ablation may become symptomatic and develop this AVRT after
AP ablation.
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Background: Arrhythmic storm (AS) was defined for the purpose of the
present study as the occurrence of frequent episodes (more than 3/day) of
hemodynamically destabilizing ventricular tachycardia or ventricular fibrilla-
tion requiring immediately electrical cardioversion or defibrillation. The aim
of this study was to determine the prevalence, causes and long-term prognosis
of AS in patients with dilated cardiomyopathy, in whom an ICD was
implanted for primary prevention.
Methods: This observational study compromised 135 pts (114 M, 21 F, 69
±20 years old). The NYHA class was II (20pts), III (105pts), IV (10pts). The
LVEF was 30 ±8%. The F.U period was 25±15 months
Results: AS occurred in 8 (6%) pts at an average of 18±7 months after
ICD implantation. The mean number of arrhythmic episodes constituting AS
was 25 ±22 (range 6 to 82) per pt. Hospital admission was required for 6 pts.
The presumed causes of AS were: a) deterioration of the clinical status in 5pts,
b) electrolyte disturbances (hypokalemia) in 2pts, c) unknown in 1pt. The
LVEF of pts with AS was 23± 9%(p<0.05). The pts with AS caused by wors-
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ening of their clinical status had an overall mortality at 6 months of 25%, and
at 1 year of 63%.
Conclusions: 1) Arrhythmic storm is associated with a poor prognosis in
nonischemic pts, 2) The triggering factors include mainly the deterioration of
the clinical status.
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Introduction: The coexistence of Mahaim fibbers (MF) and hypertrophic
cardiomyopathy (HCM) is exceptional. We report an unusual case of a young
female patient presenting with HCM and MF. 
Case-report: A 17 y/o woman was referred in 1998 for a familial HCM
screening. She had no symptoms; her surface EKG revealed a preexcitation
suggesting a right anteroseptal WPW syndrome. The transthoracic echocardio-
gram (TTE) demonstrated an asymmetric septal HCM without LV outflow
tract (LVOT) obstruction. The electrophysiological study (EPS) demonstrated
the presence of MF (normal AH interval, a short and fixed HV interval and
atrial pacing produced AH prolongation without change of preexcitation
degree, indicating fasciculo-ventricular MF). 
Eight years later (25 y/o) while the patient was doing well, the ECG was
similar and TEE demonstrated the same aspect of asymmetric septal HCM
without obstruction. Three months later the patient was pregnant and gave
birth to a healthy baby. (During pregnancy: Delta wave was present and there
was no LVOT obstruction). After delivery, Surprisingly there was no more
preexcitation on her ECG and the TEE demonstrated now a significant LVOT
obstruction with a systolic anterior motion of the mitral valve and an LVOT
gradient of 36 mmHg. A second EPS was performed in 2008 and showed no
more preexcitation. We speculate the hypothesis that FV fiber played in this
case a similar pathogenic role as does the apical right ventricular pacing when
it is used to decrease LVOT gradient in patients with HCM.
Conclusion: This case deserves to be reported because the association of
MF and HCM is rare (only 3 cases reported in english litterature), the disap-
pearance of MF during pregnancy has never been reported and the hypothesis
that the RV preexcitation via FV Mahaim fiber played a role in decreasing
LVOT gradient in this patient with HCM.
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Introduction: The purpose of this study was to determine whether left
atrial appendage flow velocity, as determined using trans esophageal echocar-
diography (TEE), predicts the outcome after catheter ablation of persistent
atrial fibrillation( PAF).
Method: 40 PAF patients (85% males, 60 +/- 11 years) underwent a step-
wise ablation approach. The procedural end point was termination of persistent
AF by catheter ablation, either by conversion directly to sinus rhythm or to
atrial tachycardia. Left atrial appendage (LAA) peak flow velocities were mea-
sured with transesophageal echography and averaged within each RR interval
of 10 consecutive cardiac cycles. Others parameters LA area, left ventricular
ejection fraction, duration of continuous AF, Administration of amiodarone,
were analyzed to determine the factors associated with procedural termination
of arrhythmia. 
Results: Among the 40 patients, all received a circumferential PV isolation, a
linear ablation, and a continuous CFE ablation. Atrial fibrillation was terminated
in 26 patients (65%) with a mean procedure time of 201 min+/-43 min. The pre-
procedural ejection fraction (p = 0.38), duration of continuous AF (p = 0.09) did
not differ significantly between patients who had success of catheter ablation com-
pared with those who had not. Peak emptying velocities of the LAA before cath-
eter ablation were significantly higher in patients in whom PAF was terminated
during the procedure (0.23 vs. 0.34, p = 0.002). On multivariate logistic regression
analysis, only the mean LAA peak emptying velocity > 0.30 cm/s (p = 0.02, odds
ratio [OR] = 9, 58 confidence interval [CI] 95% = 1.50 to 61.36), predicted suc-
cessful catheter ablation for PAF. At 6 months follow-up, patients who underwent
continued to have sinus rhythm, were significantly (p= 0, 003) higher in group
who have LAA flow velocity > 0, 30.
Conclusion: High LAA flow velocity assessed by TEE is a clinically
useful pre-ablation tool for predicting successful catheter ablation for persis-
tent atrial fibrillation and maintenance of sinus rhythm.
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Introduction: Dual-chamber (DC) pacing benefits are impaired by the
occurrence of atrial arrhythmias (AA). Pacemakers (PM) have been enhanced
by a mode-switch function (MSF) which allows the switch from DDD(R) to
DDIR pacing in presence of AA.
Materials and methods:  We analyzed MSF at 6 and 12-month (m)
follow-up in 369 patients (Pts) aged 77+/-9 y, free of permanent AA (59%),
implanted with Kappa® DC PMs (Medtronic, MN, USA) for II and III AV
block (65%), and sinus dysfunction (SD) (35%). 52% had no cardiopathy and
there was no difference in electrical parameters at implant regardless lead and
indication.
No specific programming was imposed. MS function data was collected at
each follow-up: number of MS, average percentage of time in AA. EGM was
used to confirm AA in most cases. 
Results: The MSF shows AA episode rate of 61% at 6 m and 48% at 12
m. Moreover, 29% of pts (Gr1) had no AA during the 12 m, 11% had AA only
during the last 6 m (Gr2), 24% only during the first 6 m (Gr3 and Gr5) and
37% during the 12 m (Gr4 and Gr6). Statistically, there was no significant dif-
ference between groups concerning the number of MS and between the per-
centage of time in AA at each follow-up .
Discussion: Long-term follow-up confirms results already described in the
literature, and the MS event counters may predict the existence of AA.  EGM
confirms the specificity of this function. Number of MS is significantly high
in SD (p<0.05), whereas the observation of a high number of MS may also
point to oversensitivity of the MSF. Percentage time spent in AA is a revealing
parameter, as it represents average time during which pts had been in AA
since the previous follow-up. 
Conclusion: This study confirms that AA occurrence remains an important
complication in PM patients, regardless indication. Simple examination of MS
recordings can lead to suspicion of major AA. The gravity of this AA can be
quickly determined, but only detailed examination of MS episodes can con-
firm the diagnosis.
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Background: The success rate of left ventricular (LV) lead implantation
for cardiac resynchronization therapy (CRT) is high. Congenital abnormalities
of the coronary sinus (CS) are rare but can be responsible for unsuccessful
implantation. 
